Search for Clinical Trial Results

Sponsored By

Granulocytopenia - 25 Studies Found

Status Study
Terminated Study Name: Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Date: 2013-05-08
Interventions: Biological: Filgrastim Zarzio®/Filgrastim HEXAL® solution for injection was provided in prefil
Completed Study Name: GCPGC in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Date: 2011-02-06
Interventions:
  • Biological: GCPGC 3.6mg Stage

Recruiting Study Name: Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Condition: Neutropenia
Date: 2013-08-06
Interventions:
  • Drug: pegfilgrastim,30mcg/kg T
Completed Study Name: Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Condition: Neutropenia
Date: 2012-10-24
Interventions:
  • Drug: HM10460A (45 μg/kg)

Completed Study Name: Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Date: 2008-07-24
Not yet recruiting Study Name: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Condition: Febrile Neutropenia
Date: 2017-02-24
Interventions: Drug: EC-18 oral administration Other Name: EC-18 so
Terminated Study Name: Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Date: 2009-05-26
Interventions: Drug: Ezatiostat Hydrochloride Starting Dose 2000 mg orally per day in two divided doses with dose to in
Completed Study Name: Screening for Genes in Patients With Congenital Neutropenia
Condition: Congenital Neutropenia
Date: 2016-08-05
Interventions: Genetic: High-throughput exome sequencing
Terminated Study Name: Daptomycin Versus Placebo in Patients With Neutropenia and Fever
Condition: Febrile Neutropenia
Date: 2010-10-04
Interventions:
  • Drug: Daptomycin 8 MG/KG IV
Completed Study Name: A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
Condition: Neutropenia
Date: 2001-01-18
Next >>>